Abstract
Cryptococcus neoformans is an invasive human fungal pathogen that causes more than 181,000 deaths each year. Studies have demonstrated that pulmonary C. neoformans infection induces innate immune responses involving copper, and copper detoxification in C. neoformans improves its fitness and pathogenicity during pulmonary C. neoformans infection. However, the molecular mechanism by which copper inhibits C. neoformans proliferation is unclear. We used a metallothionein double-knockout C. neoformans mutant that was highly sensitive to copper to demonstrate that exogenous copper ions inhibit fungal cell growth by inducing reactive oxygen species generation. Using liquid chromatography-tandem mass spectrometry, we found that copper down-regulated factors involved in protein translation, but up-regulated proteins involved in ubiquitin-mediated protein degradation. We propose that the down-regulation of protein synthesis and the up-regulation of protein degradation are the main effects of copper toxicity. The ubiquitin modification of total protein and proteasome activity were promoted under copper stress, and inhibition of the proteasome pathway alleviated copper toxicity. Our proteomic analysis sheds new light on the antifungal mechanisms of copper.
Highlights
Cryptococcus neoformans is a commonly inhaled fungal pathogen
The metallothioneins double-knockout mutant cmt1/2DD is very sensitive to Cu stress compared with wildtype strain H99, which was consistent with previous job (Ding et al, 2013), but it did not exhibit growth retardation when NAC was added to the medium
Cu toxicity affects the virulence of C. neoformans during pulmonary infection (Ding et al, 2013), the exact mechanism has not been fully elucidated
Summary
Cryptococcus neoformans is a commonly inhaled fungal pathogen. It infects approximately 1 million individuals annually (Maziarz and Perfect, 2016) and causes over 181,000 deaths (Agustinho et al, 2018). Fifteen percent of AIDS-related deaths were reported to be associated with cryptococcosis. It affects immunocompetent individuals (Datta et al, 2009; Kronstad et al, 2011; Andreou et al, 2020). Cryptocccal Proteome Accommodating Copper Toxicity areas (Agustinho et al, 2018). Improved therapies are required to overcome challenges such as drug cost and availability, toxic side effects, lengthy treatment regimens, and resistance
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.